Chromosomal instability (CIN) correlates with tumour metastasis 1,2 , but it remains unclear whether it is a mere bystander or a driver of metastatic progression. Chromosomally unstable cells show evidence of chromosome missegregation during anaphase 3,4 , offering an attractive bottleneck in which to target CIN and probe its selective contribution to metastasis. Destabilization of microtubule attachments to chromosomes at the kinetochores, through overexpression of the non-motile microtubule-depolymerizing kinesin-13 family proteins KIF2B or KIF2C (also known as MCAK), directly suppresses CIN in otherwise chromosomally unstable cells [5][6][7] . Cells overexpressing KIF2B or MCAK continue to propagate abnormal aneuploid karyotypes, albeit in a stable manner 7 . As such, this approach permits direct experimental interrogation of CIN, as defined by the rate of ongoing chromosome missegregation, independently of aneuploidy, which is defined as a state of abnormal chromosome numbers.
, but it remains unclear whether it is a mere bystander or a driver of metastatic progression. Chromosomally unstable cells show evidence of chromosome missegregation during anaphase 3, 4 , offering an attractive bottleneck in which to target CIN and probe its selective contribution to metastasis. Destabilization of microtubule attachments to chromosomes at the kinetochores, through overexpression of the non-motile microtubule-depolymerizing kinesin-13 family proteins KIF2B or KIF2C (also known as MCAK), directly suppresses CIN in otherwise chromosomally unstable cells [5] [6] [7] . Cells overexpressing KIF2B or MCAK continue to propagate abnormal aneuploid karyotypes, albeit in a stable manner 7 . As such, this approach permits direct experimental interrogation of CIN, as defined by the rate of ongoing chromosome missegregation, independently of aneuploidy, which is defined as a state of abnormal chromosome numbers.
Increased CIN in human metastases
First, to determine whether CIN is associated with human metastases, we applied the weighted-genomic integrity index (wGII) as a proxy for CIN 8 to 79 matched pairs of primary tumour and brain metastasis from a published cohort 9 . Metastases showed higher wGII than primary tumours ( Fig. 1a and Extended Data Fig. 1a, b) .
Next, karyotype analysis of primary breast tumours and metastases archived in the Mitelman Database of chromosomal translocations 10 revealed a predilection for near-diploid (2n) karyotypes in primary tumours. Conversely, metastases were enriched for cells with neartriploid (3n) karyotypes and had twice as many structural or numerical chromosomal aberrations per clone as primary tumours. The number of chromosomal aberrations was highest in tumour samples with karyotypes ranging between the diploid and tetraploid (4n) range (Fig. 1b, c and Extended Data Fig. 1c, d) .
Finally, histological analysis of primary tumours from patients with locally advanced head and neck squamous cell carcinoma 11 revealed a significant association (P < 0.05) between anaphase chromosome missegregation and the incidence of lymph node metastasis ( Fig. 1d and Extended Data Fig. 1e ).
CIN is a driver of metastasis
To determine whether CIN is causally involved in metastasis, we used transplantable metastatic tumour models of human (MDA-MB-231) or mouse (4T1) triple-negative breast cancer and human lung adenocarcinoma (H2030), in which 47%, 55%, and 67% of anaphase cells, respectively, show evidence of chromosome missegregation. Overexpression of KIF2B or MCAK suppressed chromosome missegregation, whereas overexpression of a dominant-negative MCAK mutant 12 (dnMCAK) led to a modest increase in chromosome missegregation in MDA-MB-231 cells. Overexpression of KIF2B or MCAK did not alter cellular proliferation or the number of centrosomes per cell (Fig. 2a, b and Extended Data Fig. 1f-i) . As a control, we overexpressed KIF2A, a third member of the kinesin-13 family that lacks kinetochore and centromere localization domains 13 ; although KIF2A showed microtubuledepolymerizing activity on interphase microtubules, it had no observable effect on CIN ( Fig. 2b and Extended Data Fig. 1i-k) . We ruled out a direct role for kinesin-13-mediated microtubule depolymerization in Article reSeArcH activating small GTPases 14 by performing RhoA and Rac1 pull-down assays, which revealed low basal levels of activity and no correlation with overexpression of kinesin-13 family proteins (Extended Data Fig. 2a, b) . Hereafter, we refer to cells expressing MCAK or KIF2B as CIN-low and to control cells or those expressing KIF2A or dnMCAK as CIN-high.
Karyotyping of the parental MDA-MB-231 cells revealed a widely aneuploid (approximately 3n) chromosome content with widespread karyotypic heterogeneity (Extended Data Fig. 2c ). Suppression of CIN reduced both numerical and structural karyotypic heterogeneity in single-cell-derived clones, as supported by the presence of fewer chromo somes exhibiting non-clonal structural abnormalities and decreased numerical chromosome heterogeneity in CIN-low cells (Extended Data Fig. 2c-h ). Notably, CIN-low cells maintained highly aneuploid karyotypes, but faithfully propagated them in a stable manner. Thus, by comparing chromosomally stable aneuploid cells to their chromo somally unstable aneuploid counterparts, we can experimentally examine the role of CIN, independent of aneuploidy, in metastasis.
We injected MDA-MB-231 cells into the left cardiac ventricles of athymic mice to enable systemic dissemination while tracking metastatic colonization using a bioluminescence reporter. Differences in chromosome missegregation rates had a marked effect on colonization: mice harbouring CIN-high cells rapidly succumbed to metastatic disease, with a median survival of 70 days, whereas mice injected with CIN-low cells had a lower metastatic burden and a median survival of 207 days. Many metastases from CIN-low cells waxed and waned and, at times, spontaneously resolved, whereas metastases from CIN-high cells involved multiple organs and progressed rapidly, leading to death. Similar results were obtained after injection of lung adenocarcinoma H2030 cells ( We performed orthotopic injections of MDA-MB-231 or 4T1 cells into the mammary fat pads of athymic or immune-competent BALB/c mice, respectively, followed by surgical excision of the primary tumour. Suppression of CIN had no effect on the efficiency of primary tumour implantation, and even enhanced primary tumour growth in the 4T1 model. However, in both models, suppression of CIN significantly reduced spontaneous metastasis and prolonged survival (Extended Data Fig. 3d, e) .
We then assessed chromosome missegregation in the injected cells and in cells derived from primary tumours and metastatic colonies (Fig. 3a) . We performed this analysis using MDA-MB-231 cells and two metastasis-competent xenografts (PDX) derived from patients with oestrogen receptor-positive (ER+ ) and triple-negative breast cancer (TNBC). Regardless of the CIN status of the injected cells, the majority of metastases were enriched for higher rates of chromosome missegregation, whereas cells derived from most primary tumours had significantly lower rates of CIN ( Fig. 3b-d) . For instance, when CIN-high cells (Fig. 3d , dnMCAK, blue bars) were injected into the mammary fat pad, chromosome missegregation rates decreased in the primary tumours (green bars) before increasing once more in metastases spontaneously arising within the same animal (orange bars). Right, chromosome missegregation in tumours from patients with (N+ , n = 22 patients) or without (N− , n = 18 patients) clinically detectable lymph node metastases. Boxes represent median ± interquartile range, confidence intervals (whiskers) denote 10th-90th percentiles (a, c, d), significance tested using two-sided Wilcoxon matched-pairs signed rank test (a) and two-sided Mann-Whitney test (b-d). RNA-seq of primary tumour-derived and metastasis-derived cells revealed pathways that were shared among metastases and CIN-high cells. However, metastases contained a large number of differentially upregulated EMT and inflammation-related genes that were disproportionately clustered on chromosome 1, signifying chromosome 1 -specific selection. Karyotype analysis revealed that the injected cell lines and most metastases had three copies of chromosome 1, whereas primary tumours consistently had two copies. Thus chromosome 1 loss is a recurrent event during primary tumour growth in this model (Extended Data Figs 4c-f, 5a-e).
We then performed single-cell RNA-seq (scRNA-seq) on three MDA-MB-231 cell lines-two CIN-low (KIF2B and MCAK) and one CIN-high (dnMCAK)-comprising a total of 6,821 cells. Clustering of single cells using EMT genes successfully classified most cells according to their CIN-status and revealed a fraction of cells (primarily CIN-high) that was highly enriched in mesenchymal markers (Fig. 4a) . Unsupervised graph-based clustering, based on all expressed genes, identified 12 phenotypically distinct subpopulations. One subpopulation was defined by increased expression of genes involved in EMT and metastasis (referred to as subpopulation 'M') and was concomitantly enriched for CIN signature genes. This sub population comprised 45% of dnMCAK expressing cells compared to 6% of CIN-low cells ( Fig. 4b and Extended Data Fig. 6a, b) .
In agreement with the scRNA-seq data, CIN-high cells exhibited increased migratory and invasive behaviour in vitro, and displayed evidence of actin cytoskeletal reorganization, diffuse vimentin staining, and increased cytoplasmic and nuclear localization of β-catenin (Extended Data Figs 6c, d, 7a-d). As expected, MAD2 overexpression rescued invasion and migration of MCAK-expressing cells. Furthermore, the ability of KIF2B or MCAK overexpression to suppress invasion in vitro was dependent on the cell cycle, as the addition of thymidine after transient transfection of either protein abrogated this phenotype (Extended Data Figs 6f, 7e, f and Supplementary Fig. 2 ).
CIN generates cytosolic DNA
To better define CIN-responsive pathways, we performed a gene-gene Pearson correlation analysis using scRNA-seq data and identified two large gene modules: module 1 was characterized by proliferative and metabolic pathways, whereas module 2 comprised EMT and inflammation gene sets (Fig. 5a ). There was a strong positive correlation between inflammation-related, CIN signature, and EMT genes in the scRNA-seq and bulk RNA-seq data (Figs 4b, 5b and Extended Data Fig. 4b, c) . 
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The induction of inflammatory pathways in response to CIN was unexpected and was reminiscent of a viral infection. We investigated whether CIN might introduce genomic DNA into the cytosol, thereby eliciting cellular responses normally reserved for anti-viral immunity 18, 19 . The exposure of genomic DNA to the cytosol can result from either primary nuclear or micronuclear envelope ruptures [20] [21] [22] [23] [24] . We performed live-cell imaging using a GFP reporter with a nuclear localization signal (NLS-GFP) 25 and found no correlation between CIN and the frequency of NLS-GFP leakage into the cytosol in unconfined conditions. There was even a trend towards more efficient primary nucleus repair in CIN-high cells. CIN-high nuclei ruptured more frequently only during confined migration, and this was primarily attributed to their increased ability to go through a larger number of small constrictions (Extended Data Fig. 7g-j Fig. 8a-c) . To test whether the presence of rupture-prone 20 micronuclei correlated with increased cytosolic DNA, we stained cells using two different anti-dsDNA antibodies after selective plasma membrane permeabilization and found increased cytosolic dsDNA and single-stranded DNA (ssDNA) in CIN-high cells. The dsDNA signal, which was distinct from mitochondrial staining, disappeared after treatment with doublestrand-specific-but not single-strand-specific-nuclease and after overexpression of DNASE2, confirming the specificity of these antibodies ( Fig. 5f and Extended Data Fig. 8d-h ). Quantification of dsDNA levels after subcellular fractionation revealed a fourfold reduction in cytosolic DNA in CIN-low cells compared to CIN-high cells (Fig. 5g) . Whole-genome sequencing of subcellular fractions at 30× coverage confirmed the genomic origin of cytosolic DNA (data not shown).
To determine whether missegregated chromosomes provide a source of cytosolic DNA, we used an inducible Y-chromosomespecific missegregation system established in chromosomally stable DLD-1 colorectal cancer cells 26 . Whole-chromosome fluorescence in situ hybridization (FISH) probes targeting the Y chromosome or an independent autosome (chromosome 15) revealed selective incorporation of the Y chromosome into micronuclei two days after chromosome missegregation induced by doxycycline and auxin (Dox/IAA) treatment. Notably, Y-chromosome-specific fragments were found dispersed within the cytosol 2-3 days after Dox/IAA addition, whereas the control autosome remained confined to the nucleus (Fig. 5h) , demonstrating that cytosolic DNA is generated from chromosomes undergoing high rates of missegregation Suppression of micronuclear envelope rupture by mCherry-lamin B2 overexpression 20 reduced cytosolic dsDNA staining without influencing chromosome segregation errors. Accordingly, such overexpression reduced metastasis after intracardiac or tail vein injection of MDA-MB-231 cells ( Fig. 5i and Extended Data Fig. 3g, h ).
Metastasis from cytosolic DNA response
In chromosomally stable cells, cytosolic dsDNA is scarce and is sensed by the cGAS-STING pathway 19 , leading to induction of type I interferon stimulated genes (ISGs) 22,23,27 . Indeed, induced missegregation of the Y chromosome led to the upregulation of OAS2, an ISG, and increased interferon-β production by DLD-1 cells Article reSeArcH (Extended Data Fig. 9f, g ). It is unclear how chromosomally unstable cancer cells cope with the constant presence of cytosolic DNA. We found notable localization of cGAS to approximately half of all micronuclei, as previously observed 22, 23, 27 . Impeding micronuclear rupture through lamin B2 overexpression 20 significantly diminished the relative fraction of cGAS + micronuclei (Fig. 6a, b) . Furthermore, CIN-high cells exhibited increased levels and perinuclear localization of STING, congruent with pathway activation (Fig. 6c) .
Notably, there was no evidence for robust activation of downstream canonical NF-κ B or type I interferon signalling in CIN-high cells, as evidenced by the lack of a significant increase in p65 or IRF3 phosphorylation, absence of p65 or IRF3 nuclear translocation, undetectable levels of interferon-β , and failure to induce ISGs (Extended Data Figs 8i, j, 9), in line with previous observations [28] [29] [30] . Cytosolic DNA, however, can activate the noncanonical NF-κ B pathway in a STING-dependent and TBK1-independent manner 18 . We found evidence for noncanonical NF-κ B activation in CIN-high cells, as revealed by lower levels of the precursor protein p100, a trend towards higher ratios of p52 and phosphorylated p100 relative to total p100, and reduced levels of the noncanonical NF-κ B pathway inhibitor TRAF2 31 (Extended Data Fig. 8i , j). Given the subtle differences seen at the protein level, we assessed the nuclear localization of RELB, the binding partner of p52, and observed increased nuclear localization in CIN-high cells. This was often accompanied by cytosolic staining, indicative of chronic pathway activation. STING depletion reduced nuclear localization of RELB and led to downregulation of EMT and inflammatory pathways, whereas the addition of cGAMP or overexpression of MAD2 increased nuclear RELB in MCAK-expressing cells (Fig. 6d, Extended Data Figs 4e, 9c-e) .
Bulk RNA-seq data identified a number of noncanonical NF-κ B target genes that were upregulated in response to CIN (CIN-responsive NC-NF-κ B genes). There was a robust correlation between the CIN signature, STING, and the CIN-responsive NC-NF-κ B genes in scRNA-seq data, in contrast to a weaker correlation between CIN and type I interferon targets ( Fig. 5b and Extended Data Fig. 6e) . Similarly, RNA-seq data from primary breast cancer in the TCGA database demonstrated increased expression of CIN-responsive NC-NF-κ B genes in tumours with higher levels of CIN signature gene products (Fig. 6e) , and higher expression of key regulators of the noncanonical NF-κ B pathway or its CIN-responsive target genes was associated with shorter DMFS and disease-free survival in breast and lung cancers. Conversely, increased expression of canonical NF-κ B or type I interferon regulatory factors was associated with an improved prognosis (Extended Data Fig. 10a) .
cGAS activation by cancer cells has been invoked in brain metastasis through a tumour cell-non-autonomous mechanism 32 . We found that STING and downstream noncanonical NF-κ B activity mediate metastasis in a tumour cell-autonomous fashion, as evidenced by reduction in metastatic dissemination, lifespan extension, and reduction in in vitro and in vivo invasion of CIN-high cells depleted of STING, RELB, or p100 (encoded by NFKB2). Conversely, the addition of cGAMP increased invasion and migration of CIN-low cells (Fig. 6f, g and Extended Data Figs 6f, 9j, 10b-d). These findings are in line with reported roles for the noncanonical NF-κ B pathway in EMT, cellular invasion, and metastasis [33] [34] [35] . The benefits of the noncanonical pathway may justify the scarcity of inactivating mutations in cGAS and STING among breast and lung cancers (Extended Data  Fig. 10e ).
Discussion
Our work reveals an unexpected link between CIN, chronic activation of cytosolic DNA sensing pathways, and metastasis. In addition to fuelling karyotypic heterogeneity that serves as a substrate for natural selection, ongoing chromosome missegregation is required to replenish cytosolic DNA pools and to maintain cells in a pro-metastatic state. Consequently, suppression of CIN reduces metastasis even in highly aneuploid cells. The repercussions of STING activation are contextdependent and range from senescence to tumorigenesis 21-23,27,28,30 . shRNA (g); n = 9, 7, and 9 mice for the control, STING shRNA1, and STING shRNA2 groups, respectively (f); n = 22, 10, 10, 10, and 9 mice for the control, RELB shRNA1, RELB shRNA2, NFKB2 shRNA1, and NFKB2 shRNA2 groups, respectively (g). Data shown as mean ± s. 
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Given that chromosomally unstable cells are awash with cytosolic DNA, our results raise the possibility that by suppressing downstream type I interferon signalling 30 and instead upregulating the alternative NF-κ B pathway, such cells have substituted a lethal epithelial response to inflammation with that of myeloid-derived cells 36, 37 , thereby engaging in some form of immune mimicry. Restoration of normal responses to inflammation would constitute a viable therapeutic strategy to target chromosomally unstable cells.
The emergence, and subsequent tolerance, of CIN represents an important bottleneck during tumour evolution [38] [39] [40] . We found that CIN induces a transcriptional shift from a proliferative and highly metabolic state, ideally suited for primary tumour growth, to a mesenchymal state associated with upregulation of inflammatory pathways (Figs 4b, 5a ). These two mutually exclusive states, which were recently observed in a pan-cancer genomic analysis of metastatic tumours 41 , are likely to account for the reversibility in chromosome missegregation rates seen in primary tumours and metastases, and provide an explanation for the negative effect of aneuploidy during early tumorigenesis 38, 40, 42 . These findings also lead us to suggest that CIN drives the subset of human metastases characterized by EMT and inflammation 41 .
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Microtubule growth activates Rac1 to promote lamellipodial protrusion in fibroblasts. Nat. Cell Biol. 1, 45-50 (1999 Supplementary Information is available in the online version of the paper.

MethODS
Genomic analysis of primary tumour-metastasis matched pairs. Whole-exome DNA sequence data from 79 brain metastases with matched primary tumour and normal tissue 9 were downloaded from the database of Genotypes and Phenotypes (dbGAP) and processed as described 43 to derive allele-specific segmented DNA copy number data for each sample. The weighted genome instability index (wGII), which describes the proportion of the genome that was classified as aberrant relative to tumour ploidy, was determined as described 8 . Mitelman database analysis. All available breast adenocarcinoma cases in the Mitelman database 10 were analysed. The primary literature was reviewed to determine the source of the sample (primary tumour or metastasis). When clonal karyotype was reported as a range, the average value was used for that given clone. Karyotype aberrations included structural aberrations as well as numerical deviations from the overall karyotype of the clone. Analysis of chromosome segregation in head and neck squamous cell carcinoma. We analysed primary tumour specimens from 60 patients with head and neck squamous cell carcinoma (HNSCC) 11 . Haematoxylin and eosin-stained primary tumour samples of sufficient quality for high-resolution microscopy analysis were available for forty patients. Analysis was restricted to cells fixed while undergoing anaphase, as previously described 44, 45 . Chromosome missegregation was defined by the presence of haematoxylin staining between the remaining segregating chromosomes during anaphase and was reported as the percentage of cells undergoing anaphase with evidence of chromosome missegregation, as previously described 44 . Clinical lymph node status was defined on the basis of clinical examination or radiographic evidence of lymph node tumour involvement 11 . Single-cell karyotyping. Cultures were treated with colcemid at a final concentration of 0.1 μ g ml −1 . Following 45 min incubation at 37 °C, the cultures were trypsinized, resuspended in pre-warmed 0.075 M KCl, incubated for an additional 10 min at 37 °C and fixed in methanol:acetic acid (3:1). The fixed cell suspension was then dropped onto slides, stained in 0.08 μ g ml −1 DAPI in 2× SSC for 5 min and mounted in antifade solution (Vectashield, Vector Labs). Metaphase spreads were captured using a Nikon Eclipse E800 epifluorescence microscope equipped with GenASI Cytogenetic suite (Applied Spectral Imaging). For each sample a minimum of 20 inverted DAPI-stained metaphases were fully karyotyped and analysed according to the International System of Human Cytogenetic Nomenclature (ISCN) 2013. FISH analysis. FISH analysis was performed on fixed cells prepared for singlecell karyotyping. Based on karyotype data, four chromosomes were selected to further evaluate numerical instability. Probes specific for centromere 3 (red), centromere 4 (orange) and centromere 9 (green) were purchased form AbbottVysis. The chromosome 6 centromeric probe was home-brew (PAC clone P308; labelled with green dUTP, MSKCC Molecular Cytogenetics Core Facility). Probe labelling, hybridization, post-hybridization washing, and fluorescence detection were performed according to standard laboratory procedures 26 . For each probe, three normal peripheral blood samples (GM07535, GM06875 and GM00558), obtained from Coriell Institute, were also analysed to derive cut-off values (false positive). RHOA and RAC1 pull-down assays. The activity of RHOA and RAC1 was determined using bead-based pull-down assay kits (Cytoskeleton, RHOA: BK036S, RAC1: BK035S). Cells were lysed on the tissue culture dish and rapidly snap frozen for storage until further processing. cGAMP was added for 18 h before lysis. In addition to His-tagged RHOA and RAC1, the positive and negative controls were total cell lysates supplemented with non-hydrolysable GTP or GDP, respectively. Cell culture. Cell lines were purchased from the American Type Culture Collection (ATCC). Tumour (MDA-MB-231, 4T1, HEK293, and H2030), cells were cultured in DMEM or RPMI (4T1) supplemented with 10% FBS and 2 mM l-glutamine in the presence of penicillin (50 U ml ) and streptomycin (50 μ g ml ). All cells tested negative for mycoplasma. Cell confluence was measured using IncuCyte live-cell analysis system (Essen Bioscience). Immunofluorescence microscopy. Cell fixation and antibody staining were performed as previously described 7 . In brief, cells were fixed with ice-cold (− 30 °C) methanol for 15 min (when staining for centromeres, centrosomes, cGAS, Vimentin, β -actin, IRF3, or α -tubulin) or 4% paraformaldehyde (when staining for RELB, p65, STING, ssDNA, dsDNA, COXIV, or β -catenin). Subsequently, cells were permeabilized using 1% triton for 4 min. See Supplementary Table 1 for antibody information. For selective plasma membrane permeabilization used for cytosolic dsDNA and ssDNA staining, cells were treated with 0.02% saponin for 5 min after fixation. For single-stranded (Thermo Fisher Scientific, FEREN0321) and double stranded (Life Technologies, EN0771)-specific nuclease treatment, cells were also permeabilized with 0.02% saponin for 2 min and treated with either nuclease for 10 min before fixation using 4% paraformaldehyde. TBS-BSA was used as a blocking agent during antibody staining. DAPI was added together with secondary antibodies. Cells were mounted with Prolong Diamond Antifade Mountant (Life Technologies, P36961). cGAMP (Invivogen, tlrl-nacga23) was transfected into cells at a concentration of 4 μ g ml −1 using lipofectamine 2000 that was added for 3-4 h and then replaced with regular serum-containing medium. Immunoblotting. Cells were pelleted and lysed using RIPA buffer. Protein concentration was determined using BCA protein assay and 20-30 μ g total protein was loaded in each lane. Proteins were separated by gradient SDS-PAGE and transferred to PVDF or nitrocellulose membranes. Full blots are shown in Supplementary Fig. 1 . See Supplementary Table 2 for antibody information. Band intensities on immunoblots were obtained using ImageJ (https://imagej.nih.gov/ij/) or the LI-COR Odyssey software, normalized to loading control, and background was subtracted. Ratios were normalized to control cells. Interferon-β levels from conditioned medium were measured using the Human IFN beta ) were seeded into 4-well chamber slides and treated with doxycycline (DOX, Sigma-Aldrich) and indole-3-acetic acid (IAA, Sigma-Aldrich) for up to 3 days to induce Y chromosome missegregation and micronuclei. Slides were washed in PBS, fixed in 3:1 methanol:acetic acid for 15 min at room temperature, and dehydrated with 80% ethanol. Chromosome paint FISH probes targeting chromosomes Y and 15 (MetaSystems) were mixed at equal ratios, applied to cells, sealed with a coverslip, and co-denatured at 75 °C for 2 min followed by overnight hybridization at 37 °C in a humidified chamber. Slides were washed in 0.4× saline-sodium citrate (SSC) buffer for 2 min at 72 °C, followed by a 30 s wash in 2× SCC, 0.05% Tween-20 buffer at room temperature. Cells were counterstained with DAPI and captured on a DeltaVision Elite (GE Healthcare) microscope system at 60× magnification (25 × 0.2 μ m z-stacks) followed by image deconvolution and maximum intensity quick projection. Knockdown and overexpression constructs. Luciferase expression was achieved using pLVX plasmid (expressing tdTomato) and cells stably expressing luciferase were selected using hygromycin and sorted for tdTomato expression. Kinesin-13 family protein expression was achieved using plasmid (pEGFP) transfection or lentiviral (pLenti-GIII-CMV-GFP-2A-Puro) expression where cells were selected using G418 (0.5 mg ml −1 ) or puromycin (5 μ g ml −1 ), respectively. DNASE2 overexpression was achieved using a pLenti-GIII-CMV-RFP-2A-Puro plasmid with puromycin used for selection. Plasmids containing kinesin-13 proteins or lamin B2 (pQCXIB-mCherry-lmnb2) constructs were offered by the Compton and Hetzer Laboratories, respectively. Blasticidin was used to select for lmnb2-expressing cells at 10 μ g ml −1
. All other plasmids were purchased from Applied Biological Materials (https://www.abmgood.com/). Stable knockdown of STING, NFKB2, RELB, and cGAS were achieved using shRNAs in pRRL (SGEP or SGEN) plasmids obtained from the MSKCC RNA Interference Core. Two to four distinct shRNA hairpins were screened per target. Targeted shRNA sequences are listed in Supplementary Table 3 . To visualize primary nuclear rupture, cells were stably modified with a retroviral construct expressing both NLS-GFP 25 and H2B-Tdtomato (3× NLScopGFP-P2A-H2BtdTomato-IRES-puromycin). Cells were cultured for 24 h after viral transduction before selection with 1 μ g ml −1 puromycin and subsequently sorted to select for NLS-GFP and H2B-TdTomato expression. Cell migration in microfluidic devices. Microfluidic migration devices with precisely defined constrictions were prepared as described previously 25, 46 . Devices were coated with 50 μ g ml −1 type-I rat tail collagen (BD Biosciences) in 0.02 M acetic acid overnight at 4 °C. Approximately 80,000 cells were seeded (in DMEM supplemented with 10% FBS and 1% PenStrep) per migration chamber. Devices were placed in a tissue-culture incubator (37 °C) for 5-6 h to allow the cells to adhere. Subsequently, the medium was changed to phenol-red free Leibovitz L15 medium supplemented with 10% FBS and 1% PenStrep before the device was mounted on an inverted microscope (Zeiss Observer Z1) equipped with a temperature-controlled stage (37 °C) for live-cell imaging. The medium reservoirs of the device were covered with glass coverslips to minimize evaporation during live-cell imaging. Cells were imaged for 14-16 h at 10-min intervals with a CCD camera (Photometrics CoolSNAP KINO) using a Zeiss 20× /NA 0.8 air objective. 
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at relative hazard ratios of < 0.2 or > 5 with 80% power and 95% confidence, given a median disease-specific survival of 3 months in the control group and a total follow up period of 250 days. For the 4T1 experiments, power analysis indicated that ten mice per group would be sufficient to detect a difference at relative hazard ratios of < 0.25 or > 4.0 with 80% power and 95% confidence, given a median survival of 58 days in the control group and a total follow up period of 180 days. There was no need to randomize animals. Investigators were not blinded to group allocation. Intracardiac injection was performed as previously described 32 . In brief, cells were trypsinized and washed with PBS and 1 × 10 5 cells (in 100 μ l PBS) were injected into the left cardiac ventricle of female athymic 6-7-week-old athymic nude (nu/nu) mice (Jackson Laboratory strain 002019). Cells (2 × 10 5 ) were injected into the tail vein cohort of animals. Mice were then immediately injected with d-luciferin (150 mg kg ) and subjected to bioluminescence imaging (BLI) using tan IVIS Spectrum Xenogen instrument (Caliper Life Sciences) to ensure systemic dissemination of tumour cells. Metastatic burden was measured 5-7 weeks after injection using BLI. BLI images were analysed using Living Image Software v.2.50. Disease-specific survival endpoint was met when the mice died or met the criteria for euthanasia under the IACUC protocol and had radiographic evidence of metastatic disease. For orthotopic tumour implantation, 2.5 × 10 5 cells in 50 μ l PBS were mixed 1:1 with Matrigel (BD Biosciences) and injected into the fourth mammary fat pad. Only one tumour was implanted per animal. MDA-MB-231 primary tumours were surgically excised before they reached ~ 1.5 cm in the largest dimension (which was the maximum allowable under our IACUC protocol) and metastatic dissemination was assessed using BLI imaging at 1-3-week intervals for up to 30 weeks. The distant metastasis-free survival endpoint was met when BLI signal was seen outside the site of primary tumour transplantation. 4T1 tumours were excised 8-9 days after implantation. To derive short-term culture from primary tumours and metastases, anesthetized mice (isofluorane) were imaged then killed. Ex vivo BLI was subsequently performed on removed organs to define the precise location of the metastatic lesion. Primary tumours and metastases were subsequently mechanically dissociated and cultured in DMEM with selection medium (G418 or hygromycin) to select for tumour cells and exclude host cells. All subsequent assays (karyotyping, RNA-seq, immunofluorescence, and subcellular fractionation) were performed after a single passage from the primary sample. To assess chromosome missegregation from primary tumour-derived and metastasisderived cells, we performed high-resolution immunofluorescence analysis on passage no. 1 cells, staining for DNA (DAPI) and centromeres (ACA). The presence of cells with DNA or centromere staining in the middle of the anaphase plate was taken as evidence of chromosome missegregation. Patient-derived xenograft assays. Patient-derived xenograft (PDX) models of human metastatic breast cancers were generated by transplanting the freshly obtained surgically excised tumour specimens from patients who had given consent under the IRB approved protocol (MSKCC IRB #97-094) in female NOD/SCID/IL2Rγ null (NSG) mice (Jackson Laboratories strain 005557). All relevant ethical regulations were followed. The oestrogen receptor-positive PDX was derived from breast cancer metastatic to the bone. The TNBC PDX was established from an axillary lymph node metastasis from a patient with inflammatory breast cancer. PDXs were maintained for a maximum of three serial passages. In brief, freshly obtained tumour tissue specimens were either directly transplanted in the mammary fat-pad of the mice or minced into 1-2-mm pieces in serum-free MEM medium with nonessential amino acids (Cat. No. 41500018, Thermo Fisher Scientific) transduced with lentiviral vectors expressing either GFP-luciferase or pUltra-Chili-Luc plasmid (Addgene plasmid: 48688) followed by transplantation into mice. Typically PDX tumour growth became evident during the first 1-3 weeks after engrafting and tumours continued to grow for an additional 4-8 weeks. Primary tumour growth and metastases were followed using BLI or spectrum CT imaging. At the time of removal of primary tumours and metastases, we derived primary cell cultures directly from primary tumours as well as lung and liver metastases. In brief, 500 mg of fresh bulk tumour tissue was chopped into 1-2-mm 3 pieces and incubated in Accutase (AT104; Innovative Cell Technologies) for cell detachment and separation over 1-2 h. The dissociated tissues were sieved through 100-μ m cell strainers and the cells were pelleted by centrifugation at 1,200 r.p.m. The pellets were washed and resuspended in the above MEM buffer with 3% FBS. Cells were analysed for chromosome missegregation after one passage. RNA sequencing and analysis. Bulk RNA was extracted from cells using the QIAShredder (Qiagen, 79654) and the RNA extraction kit (Qiagen, 74106) and sequenced using HiSeq2500 or HiSeq4000 (Illumina). The quality of the raw FASTQ files were checked with FastQC (https://www.bioinformatics.babraham. ac.uk/projects/fastqc/). For samples originating from mouse xenografts, FASTQ reads were classified as originating from either mouse (GRCm38) or human (GRCh38) genomes using xenome 47 , and human-specific reads were used for mapping. Reads were mapped to human reference GRCh38 using STAR (v2.4.1d, 2-pass mode) 48 . Gene expression was estimated using cufflinks (v2.2.1, default parameters) and HTSeq (v0.6.1) 49, 50 . Differential expression analyses were performed using DESeq2 (v1.14.1) 51 . Pre-ranked gene set enrichment analyses were performed on the DESeq2 log 2 fold changes 52 . Prior to any unsupervised analyses, expression counts were transformed using variance stabilizing transformation using the DESeq2 R package. Gene signatures used in the study are listed in Supplementary Table 5 . Differentially expressed gene sets and their associated statistics are listed in Supplementary Table 6 . To detect potential copy number changes, positional gene enrichment analysis (PGE) was performed on the up regulated and downregulated differentially expressed genes, separately (padj ≤ 0.1) 53 . Only significant regions with four or more genes and with P ≤ 0.01 were kept for further analysis. Circos plots were made using the circlize R package 54 . Reverse-transcriptase quantitative polymerase chain reaction. Cells were collected into trizol reagent (Thermo Fisher Scientific) and total RNA was extracted using 'Pureling RNA mini kit' (Thermo Fisher Scientific) according to the manufacturer's instructions. Total RNA (5 μ g) was used for RT-PCR using the RNA to cDNA Ecodry premix (oligo dT) cDNA synthesis kit (Clontech) according to the manufacturer's instructions. Resulting cDNA corresponding to 50 ng total RNA was used in each 20 μ l of quantitative real time PCR reaction. qRT-PCR was performed using SybrGreen master mix (Biorad) and the relative expression of each gene was calculated after normalizing to ACTB endogenous control and using the comparative Δ C t method. A list of the primers used is in Supplementary Table 4 . Single-cell RNA sequencing. Cells were trypsinized and resuspended in PBS. Twenty-one microlitres of a cellular suspension at 400 cells per microlitre, > 95% viability, were loaded onto to the 10X Genomics Chromium platform to generate barcoded single-cell GEMs. scRNA-seq libraries were prepared according to 10X Genomics specifications (Single Cell 3′ Reagent Kits User Guide PN-120233, 10X Genomics). GEM-reverse transcription (RT) (55 °C for 2 h, 85 °C for 5 min; held at 4 °C) was performed in a C1000 Touch Thermal cycler with 96-Deep Well Reaction Module (Bio-Rad). After RT, GEMs were broken and the single-strand cDNA was cleaned up with DynaBeads MyOne Silane Beads (Thermo Fisher Scientific) and SPRIselect Reagent Kit (0.6 × SPRI; Beckman Coulter). cDNA was amplified for 14 cycles using the C1000 Touch Thermal cycler with 96-Deep Well Reaction Module (98 °C for 3 min; 98 °C for 15 s, 67 °C for 20 s, and 72 °C for 1 min × 14 cycles; 72 °C for 1 min; held at 4 °C). The quality of the cDNA was analysed using an Agilent Bioanalyzer 2100. The resulting cDNA was sheared to ~ 200 bp using a Covaris S220 instrument (Covaris) and cleaned using 0.6× SPRI beads. The products were end-repaired, ' A'-tailed and ligated to adaptors provided in the kit. A unique sample index for each library was introduced through 10 cycles of PCR amplification using the indexes provided in the kit (98 °C for 45 s; 98 °C for 20 s, 60 °C for 30 s, and 72 °C for 20 s × 14 cycles; 72 °C for 1 min; held at 4 °C). After two SPRI cleanups, libraries were quantified using Qubit fluorometric quantification (Thermo Fisher Scientific) and the quality assessed on an Agilent Bioanalyzer 2100. Four libraries were pooled and clustered on a HiSeq2500 in rapid mode at 10 pM on a pair end read flow cell and sequenced for 98 cycles of R1, followed by 14 bp I7 Index (10X Barcode), 8 bp I5 Index (sample index) and 10 bp on R2 (UMI). Primary processing of sequencing images was done using Illumina's Real Time Analysis software. Demultiplexing and post processing was done using the 10X Genomics Cell Ranger pipeline per the manufacturer's recommendations. scRNA-seq data were processed from raw reads to a molecule count array using the Cell Ranger pipeline 55 . Additionally, to minimize the effects of experimental artefacts on the analysis, data were pre-processed to filter out cells with low total molecule counts (library size), low complexity and high mitochondrial content, identified by a bimodal fit. The remaining cells were normalized by dividing the expression level of each gene in a cell by its total library size and then scaling by the median library size of all cells. After normalizing by library size, we performed principal component analysis to improve the robustness of the constructed Markov matrix generated when computing diffusion eigenvalues for imputation of dropout noise 56 . We chose the number of principal components to retain approximately 80% of variance in the data and excluded the first principal component, which was highly correlated with library size. Imputation of both the normalized and unnormalized count matrix was performed using a Markov matrix raised to the power of 3 (power corresponds the approximate number of weighted nearest neighbours) and with a gene expression distribution computed according to 21 nearest neighbouring cells, as described 56 . Our analysis was robust to imputation and we obtained similar results without imputed data (not shown). Subpopulations were identified using Phenograph 57 and genes differentially expressed in at least one subpopulation were identified by the Kruskal-Wallis rank statistic using a bootstrapping method for random downsampling of matched molecule and cell counts from each subpopulation. t-SNE was used to visualize subpopulation structure based on the first 20 principle components of the imputed count matrix, subsetted by the top Article reSeArcH 5,150 differentially expressed genes (FDR q of Kruskal-Wallis rank statistic < 0.05). The mean expression of key gene signatures in population M versus other subpopulations was z-normalized and visualized using violin plots. All gene signatures are annotated in Supplementary Table 5 . The correlation between gene signatures was computed using the Spearman rank correlation coefficient according to the mean expression of all genes per signature per cell. Ward's minimum variance method was applied to hierarchically cluster cells by their normalized expression of differentially expressed EMT genes. Patient survival analysis. Genes used for survival analysis are listed in Supplementary Table 5 . For the meta-analysis cohort, we used aggregate data from KMPlot 16,58 (http://www.kmplot.com) using only JetSet best probe set and autoselection for best cutoff between the 25th and 75th percentiles. For the validation cohort in which DMFS data were available 17 , we used the z-normalized expression data for a data set and the median value was used as a cutoff. DMFS curves were compared using the log-rank test. In vitro invasion and migration assays. For the invasion and migration/ chemotaxis assays we used the CytoSelect cell invasion (CBA-110) and cell migration (CBA-100) kits, respectively. In brief, 3 × 10 5 cells were suspended in serum-free medium and placed on top of the membrane. Medium containing serum was placed at the bottom and cells that had invaded to the inferior surface of the collagen membrane were stained and counted 18-24 h later. For experiments involving transient transfection, cells were transfected, and thymidine (2 mM) was added 18 h later. Cells were plated on the membrane 3 days after transfection. For the chemotaxis assay, we used a colorimetric approach (OD 560 nm) for quantification. For the scratch assay, cells were treated with mitomycin C (10 μ g ml
) for 1 h when they reached > 90% confluence and then placed in DMEM containing 1% FBS. Wounds were applied using a p200 pipette tip and images of the wounds were taken immediately and at subsequent regular intervals. ImageJ was used for quantification of wound surface area. Quantification of cytosolic DNA. Approximately 1 × 10 7 cells were lysed and the nuclear, cytosolic, and mitochondrial fractions were obtained using the mitochondrial isolation kit (Thermo Fisher Scientific, 89874). Protease inhibitors were not used to enable subsequent DNA purification. Mitochondria were purified by centrifugation at 12,000g to minimize their contamination in the cytosolic fraction. DNA was subsequently isolated from the nuclear, cytosolic, mitochondrial fractions using the Qiagen DNeasy blood and tissue kit (Qiagen, 69506) and dsDNA was quantified using Qubit 2.0 (Invitrogen) with Qubit dsDNA HS Reagent. Code availability. All custom code, statistical analysis, and visualizations were performed in Python or R, and used Nextflow to manage some of the computational pipelines 59 . Code for the RNA sequencing analysis is available online at: https:// github.com/murphycj/manuscripts/tree/master/BakhoumEtAl2017. The live-cell tracking MATLAB 2016a code can be found at https://github.com/Lammerding/ MATLAB-CellTracking. 
Extended Data Figure 10 | Effect of cytosolic DNA-sensing pathways on prognosis. a, Distant metastasis-free survival (DMFS), relapse-free survival (RFS) and progression-free survival (PFS) of patients with breast and lung, stratified according to their expression of NF-κ B and interferon pathways. Significance tested using two-sided log-rank test. b, Diseasespecific survival of mice injected with dnMCAK-expressing MDA-MB-231 cells co-expressing control shRNA, STING shRNA, NFKB2 shRNA, or RELB shRNA. n = 35, 16, 19, and 20 mice in the control, STING shRNA, NFKB2 shRNA, and RELB shRNA groups, respectively; significance tested using two-sided log-rank test. c, Number of MDA-MB-231 cells expressing shRNA targeting genes belonging to the DNA-sensing or noncanonical NF-κ B pathways that invaded through a collagen membrane within 24 h of culture. Data shown as mean ± s.d., * * P < 0.0001, two-sided MannWhitney test, n = 20 high-power fields, two independent experiments performed. d, Number of different normal tissues (vascular, neuronal, or soft tissue) invaded by orthotopically transplanted tumours. Data shown as mean ± s.e.m., * P < 0.05, two-tailed t-test, n = 13 tumours (CINhigh), 20 tumours (noncanonical NF-κ B depleted), 19 tumours (cGAS-STING depleted). e, Oncoprints showing genomic alterations in STING (TMEM173) and cGAS (MB21D1) in breast and lung cancers from the TCGA database.
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Bulk RNA seq code is made publicly available (link in the methods section). Single cell RNAseq was analyzed using Python and already-published data and was appropriately referenced in the methods section. Wound healing assay (surface area) was analyzed using ImageJ. Single cell analysis was performed using Python 3.0. Cell migration using microfluidics devices was performed using MATLAB 2016a. RNAseq data was performed using R For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials 8. Materials availability Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
There are no restrictions for distribution of research materials produced during this study.
nature research | life sciences reporting summary June 2017 9. Antibodies Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Pre-validated antibodies were purchased from reputable sources (Cell signaling technology and abcam). Antibodies and their catalog numbers are listed in Supplementary information. Most antibodies were further validated when the target protein was depleted using shRNA.
Supplementary Table 1. Antibodies used in immunofluorescence.
Antibody against Company Catalog number α-tubulin Sigma Aldrich T9026 β-actin Abcam ab8227 β-catenin Abcam ab16051 cGAS Sigma Aldrich HPA031700 Cox IV Abcam ab16056 dsDNA (Extended Fig. 8d ) Abcam AB27156 dsDNA (Fig. 5f) None of the cell lines used are listed in the ICLAC database.
